PTC Therapeutics, Inc. today announced that management will present a company update at the J.P. Morgan Healthcare Conference on Tuesday, January 8th at 5 p.m. PST.
SOUTH PLAINFIELD, N.J., Jan. 2, 2019 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that management will present a company update at the J.P. Morgan Healthcare Conference on Tuesday, January 8th at 5 p.m. PST.
The presentation will be webcast live on the Events and Presentations page under the investor relations section of PTC Therapeutics’ website at www.ptcbio.com and will be archived for 2 weeks following the presentation. It is recommended that users connect to PTC’s website several minutes prior to the start of the webcast to ensure a timely connection.
About PTC Therapeutics, Inc.
PTC is a science-led, global biopharmaceutical company focused on the discovery, development and commercialization of clinically-differentiated medicines that provide benefits to patients with rare disorders. PTC’s ability to globally commercialize products is the foundation that drives investment in a robust pipeline of transformative medicines and our mission to provide access to best-in-class treatments for patients who have an unmet medical need.
FOR MORE INFORMATION PLEASE CONTACT:
| Media: | Investors: |
| Jane Baj | Emily Hill |
| +1 (908) 912-9167 | +1 (908) 912-9327 |
View original content:http://www.prnewswire.com/news-releases/ptc-therapeutics-to-participate-at-upcoming-investor-conference-300771885.html
SOURCE PTC Therapeutics, Inc.
Company Codes: NASDAQ-NMS:PTCT
